Gambling.com Group (GAMB) is drawing fresh attention after reporting 2025 results that combined higher sales with a full year net loss, impairment charges on intangible assets, new 2026 revenue ...

The FDA has issued a formal warning letter to Novo Nordisk regarding deficiencies in how it reports serious and unexpected adverse events for products including GLP-1 drugs like Ozempic and Wegovy.